These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24178369)

  • 41. Preoperative fasting plasma C-peptide level may help to predict diabetes outcome after gastric bypass surgery.
    Aarts EO; Janssen J; Janssen IM; Berends FJ; Telting D; de Boer H
    Obes Surg; 2013 Jul; 23(7):867-73. PubMed ID: 23475775
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial.
    Halperin F; Ding SA; Simonson DC; Panosian J; Goebel-Fabbri A; Wewalka M; Hamdy O; Abrahamson M; Clancy K; Foster K; Lautz D; Vernon A; Goldfine AB
    JAMA Surg; 2014 Jul; 149(7):716-26. PubMed ID: 24899464
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes.
    Rubino F; Forgione A; Cummings DE; Vix M; Gnuli D; Mingrone G; Castagneto M; Marescaux J
    Ann Surg; 2006 Nov; 244(5):741-9. PubMed ID: 17060767
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of modified biliopancreatic diversion on glucose tolerance of GK rats.
    Weng SG; Zhang B; Feng S; Xu CG; Lin CZ
    Obes Surg; 2013 Apr; 23(4):522-30. PubMed ID: 23207830
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ghrelin, leptin, and glycemic control after sleeve gastrectomy versus Roux-en-Y gastric bypass-results of a randomized clinical trial.
    Kalinowski P; Paluszkiewicz R; Wróblewski T; Remiszewski P; Grodzicki M; Bartoszewicz Z; Krawczyk M
    Surg Obes Relat Dis; 2017 Feb; 13(2):181-188. PubMed ID: 27692906
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expedited Biliopancreatic Juice Flow to the Distal Gut Benefits the Diabetes Control After Duodenal-Jejunal Bypass.
    Han H; Wang L; Du H; Jiang J; Hu C; Zhang G; Liu S; Zhang X; Liu T; Hu S
    Obes Surg; 2015 Oct; 25(10):1802-9. PubMed ID: 25726319
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Prospective Single-Arm Trial of Modified Long Biliopancreatic and Short Alimentary Limbs Roux-En-Y Gastric Bypass in Type 2 Diabetes Patients with Mild Obesity.
    Murad AJ; Cohen RV; de Godoy EP; Scheibe CL; Campelo GP; Ramos AC; de Lima RC; Pinto LEV; Coelho D; Costa HBF; Pinto ÍMP; Pereira T; Teófilo FRS; Valadão JA
    Obes Surg; 2018 Mar; 28(3):599-605. PubMed ID: 28933045
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biliopancreatic Limb Length of Small Intestinal Bypass in Non-obese Goto-Kakizaki (GK) Rats Correlates with Gastrointestinal Hormones, Adipokines, and Improvement in Type 2 Diabetes.
    Zhang Q; Hong Z; Zhu J; Zeng C; Tang Z; Wang W; Huang H
    Obes Surg; 2021 Oct; 31(10):4419-4426. PubMed ID: 34312782
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Laparoscopic gastric bypass for the treatment of type 2 diabetes: a comparison of Roux-en-Y versus single anastomosis gastric bypass.
    Almalki OM; Lee WJ; Chong K; Ser KH; Lee YC; Chen SC
    Surg Obes Relat Dis; 2018 Apr; 14(4):509-515. PubMed ID: 29555031
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of Roux-en-Y operations on glucose homeostasis in obese GK rats.
    Zhang X; Huang W; Zhang Y; Zhou W; Zhou L; Huang Z; Qu J; Gao G; Huo S; Kong F; Zhang JF
    Surg Endosc; 2011 Nov; 25(11):3493-8. PubMed ID: 21853396
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of sitagliptin on glucose control in type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery.
    Shah A; Levesque K; Pierini E; Rojas B; Ahlers M; Stano S; Holter M; Dutia R; Belsley S; McGinty J; Laferrère B
    Diabetes Obes Metab; 2018 Apr; 20(4):1018-1023. PubMed ID: 29072800
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Decreased serum betatrophin levels correlate with improved fasting plasma glucose and insulin secretion capacity after Roux-en-Y gastric bypass in obese Chinese patients with type 2 diabetes: a 1-year follow-up.
    Guo K; Yu H; Lu J; Bao Y; Chen H; Jia W
    Surg Obes Relat Dis; 2016 Aug; 12(7):1343-1348. PubMed ID: 27178609
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Roux-en-Y gastric bypass promotes expression of PDX-1 and regeneration of beta-cells in Goto-Kakizaki rats.
    Li Z; Zhang HY; Lv LX; Li DF; Dai JX; Sha O; Li WQ; Bai Y; Yuan L
    World J Gastroenterol; 2010 May; 16(18):2244-51. PubMed ID: 20458761
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Establishment of a new gastric bypass animal-model with GK rats].
    Sun QL; Wang Y; Zhang XG; Gao HK; Zhao L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Nov; 12(6):562-4. PubMed ID: 19921563
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of early type 2 diabetes improvement after gastric bypass and sleeve gastrectomy: medication cessation at discharge predicts 1-year outcomes.
    Heshmati K; Harris DA; Aliakbarian H; Tavakkoli A; Sheu EG
    Surg Obes Relat Dis; 2019 Dec; 15(12):2025-2032. PubMed ID: 31711946
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Type 2 diabetes after gastric bypass: remission in five models using HbA1c, fasting blood glucose, and medication status.
    Blackstone R; Bunt JC; Cortés MC; Sugerman HJ
    Surg Obes Relat Dis; 2012; 8(5):548-55. PubMed ID: 22721581
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preserved Insulin Secretory Capacity and Weight Loss Are the Predominant Predictors of Glycemic Control in Patients With Type 2 Diabetes Randomized to Roux-en-Y Gastric Bypass.
    Nguyen KT; Billington CJ; Vella A; Wang Q; Ahmed L; Bantle JP; Bessler M; Connett JE; Inabnet WB; Thomas A; Ikramuddin S; Korner J
    Diabetes; 2015 Sep; 64(9):3104-10. PubMed ID: 25901097
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Weight loss independent association of TCF7 L2 gene polymorphism with fasting blood glucose after Roux-en-Y gastric bypass in type 2 diabetic patients.
    Rouskas K; Cauchi S; Raverdy V; Yengo L; Froguel P; Pattou F
    Surg Obes Relat Dis; 2014; 10(4):679-83. PubMed ID: 25224167
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Roux-en-Y Gastric Bypass Surgery Suppresses Hepatic Gluconeogenesis and Increases Intestinal Gluconeogenesis in a T2DM Rat Model.
    Yan Y; Zhou Z; Kong F; Feng S; Li X; Sha Y; Zhang G; Liu H; Zhang H; Wang S; Hu C; Zhang X
    Obes Surg; 2016 Nov; 26(11):2683-2690. PubMed ID: 27038047
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effect of gastric bypass surgery on mRNA expression level of hepatic phosphoenolpyruvate carboxykinase in type 2 diabetic Goto-Kakizaki rats].
    Xie JB; Cai JL; Li LJ; Zhang LJ; Jiang MZ; Chen DG; Chen R
    Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Nov; 15(11):1146-9. PubMed ID: 23172527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.